Cryopreservation Media Market

Cryopreservation Media Market

  • HC-2580
  • 4.8 Rating
  • 206 Pages
  • 10-12-2023
  • 70 Reviews
  • PDF Excel PPT
raksha

Author :

Raksha Sharma

Vineet

Fact-checked by :

Vineet Pandey

Vishal

Editor :

Vishal Golekar

Market Outlook:

The Global Cryopreservation Media Market was estimated at USD 1,531.7 Million in 2022 and is anticipated to reach USD ~4,350.5 Million by 2031, expanding at a CAGR of 12.5% during the forecast period.

Cryopreservation or cell freezing refers to using low temperatures to specifically preserve structurally intact living cells. The science that deals with cryopreservation is called cryobiology. Proper cryopreservation of cells is the suitable way to save expenses, improve reproducibility of experiments, and protect important stocks of cells that are difficult to replace.

Cryopreservation Media Market Outlook

A special protective cryopreservation medium is required to achieve cells freezing, as unprotected freezing is lethal for cells. Cryopreservant increase the overall concentration of all solutes and reduce the amount of ice formed, thus, offering protection in the cell freezing process.

Macro-economic Factors

Rising GDPs of Emerging Economies

GDP growth rate of a country, the overall economic growth, and stability of countries significantly impact the cryopreservation media market across the globe. High GDP growth rates lead to increased R&D spending, including investments in oncology research, cryobiology research and others. Emerging economies such as Russia, India, and China, the UAE, and other countries in the Southeast Asia and Latin America are key destinations for the healthcare industry. The economic growth of emerging countries is growing by about 6% annually, whereas countries with an already well-established economy report growth rate below 3%.

In 2021, the total contribution of the healthcare industry to the global GDP was 10%. Israel is the second-largest economy in the Middle East & North Africa (MENA) with a GDP of USD 488 billion in 2022. Saudi Arabia is with USD 1,108.1 billion GDP in 2022. Countries with high GDP growth rate tends to have high healthcare expenditure, which increases the demand for cryopreservation media in the region. Thus, rising GDPs of emerging countries play a crucial role in fueling the market.

Market Dynamics

Market Driver- Increasing Demand in Biomedical Research

Cryopreservation is widely applied in various biomedical research applications, such as transplantation, tissue regeneration, anti‐infection therapy, and anti‐tumor therapy. Biological organism‐based therapy is a promising direction of biomedicine. Living organisms or inactivated organisms are easily obtained by the freezing method. Cryopreservation achieves long‐term storage of cells that are utilized for transplantation (including pancreatic islet, hepatocyte, and bone marrow), blood transfusion, artificial insemination, and in vitro fertilization. Key factors in the success of cryopreservation are cryoprotective agents (CPAs) and temperature control. CPAs makes it possible to store cells at cryogenic temperatures and recover cell viability and functionality at high levels. Cryopreservation of cells and organs, is applied in basic research and biomedical applications. Thus, the increasing demand for cryopreservation media in biomedical research is anticipated to drive the market during the forecast period.

Market Restraint- Regulatory and Compliance Issues

Cryopreservation protocols exist for most areas of research and medicine. A GMP-manufactured, fully-defined cryopreservation media is recommended for use in highly regulated fields, such as cell and gene therapy, to ensure that the products are consistently produced and controlled according to quality standards. Stringent and complicated regulations are applied in the cryopreservation method involved in the preparation and/or storage of cell therapy materials. Factors routinely considered include sample sterility, reproducibility, efficacy, traceability, and the safety of cryoprotectants. Regulations of cells for medical use has increased the need for documented cell handling processes. Complete details of the cryopreservation process, including storage, transport, and thawing, are tracked, recorded, and retained together with the details of the samples and their history. Thus, stringent regulations and compliance issues are expected to hamper the market in the coming years.

Market Opportunity- Increasing Investment In R&D Activities

Research and development (R&D) are essential for economic growth, as it encourages innovation, invention, and progress. In recent times, the investments have fueled innovations in the healthcare industry. Continuous investment in R&D of biotechnology and medical sciences is fostering competitive advantages. In the US, medical and health research and development (R&D) investment reached USD 245.1 billion in 2020, a 11.1% increase from 2019.

Biotechnology companies are investing heavily in research and development to continually improve their products and stay ahead of the competition. This, in turn, is contributing to the overall evolution of cryopreservation media, ensuring continuous improvements in the research field. Significant investment in R&D activities of cancer research is expected to contribute to the growth of the market during the forecast period. In 2022, global oncology spending accounted for 193.0 billion USD. The cancer-drug pipeline and associated investment have been growing substantially. Presently, more than 50.0 billion USD is invested in the R&D of oncology RD annually. Thus, the rising investment in R&D is expected to create growth opportunities during the forecast period.

Scope of the Report  

The report on the global Cryopreservation Media market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
 

Attributes

Details

Report Title

Cryopreservation Media Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast

Base Year

2022

Historic Data

2016-2021

Forecast Period

2023–2031

Segmentation

By Type (Serum-free and With Serum), By End-user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Cell Banks, and Others)

Regional Scope

Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered

Thermo Fisher Scientific Inc, Lonza, STEMCELL Technologies, Merck KGaA, Danaher (Cytiva), BioLife Solutions Inc., Bio-Techne, Sartorius AG (Biological Industries), HiMedia Laboratories, NIPPON Genetics EUROPE, Capricorn Scientific, PromoCell GmbH.

 

Segmental Outlook

Based on Type, the market is segmented into serum-free and with serum. The serum-free segment is expected to hold a considerable share of the market during the forecast, as it ensures high viability of cells. Serum-free cryopreservation media is suitable for applications in stem cell and other research.

Cryopreservation Media Market Type

On the basis of End-user, the market is fragmented into pharmaceutical & biotechnology companies, academic & research institutes, cell banks, and others. The pharmaceutical & biotechnology companies held the significant share of the market in 2022, as cryopreservation media is crucial in biotechnological research and drug development.

Cryopreservation Media Market End User

Regional Outlook

Based on regions, the market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a significant share of the market in 2022, owing to the presence of highly developed research institutes in the region. Rising research and development activities in North America is expected to contribute to the growth of the market in the coming years.

Cryopreservation Media Market Regions

Key Developments:

  • In 2022, Lonza expanded the functionality of its Cocoon Platform with a new magnetic selection capability for cell therapy manufacturing.

  • In 2022, Merck KGaA announced a Euro 100 Million investment for its first Asia-Pacific Mobius Single-use Manufacturing Centre in Wuxi, China.

Key Benefits for Industry Participants & Stakeholders

  • In-depth Analysis of the Global Cryopreservation Media Market

  • Historical, Current, and Projected Market Size in Terms of Value

  • Potential & Niche Segments and Regions Exhibiting Promising Growth Covered

  • Industry Drivers, Restraints, and Opportunities Covered in the Study

  • Recent Industry Trends and Developments

  • Competitive Landscape & Strategies of Key Players

Segments

By Type

  • Serum-free
  • With Serum

By End-user

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Cell Banks
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Market Players Profiled in the Report

  • Thermo Fisher Scientific Inc
  • Lonza
  • STEMCELL Technologies
  • Merck KGaA
  • Danaher (Cytiva)
  • BioLife Solutions Inc.
  • Bio-Techne
  • Sartorius AG (Biological Industries)
  • HiMedia Laboratories
  • NIPPON Genetics EUROPE
  • Capricorn Scientific
  • PromoCell GmbH

Competitive Landscape

  • Manufacturers operating in the global Cryopreservation Media market are Thermo Fisher Scientific Inc, Lonza, STEMCELL Technologies, Merck KGaA, Danaher (Cytiva), BioLife Solutions Inc., Bio-Techne, Sartorius AG (Biological Industries), HiMedia Laboratories, NIPPON Genetics EUROPE, Capricorn Scientific, PromoCell GmbH.

  • Market players are pursuing strategies such as acquisitions, product launches, collaborations, and geographic expansion to leverage untapped opportunities in the global Cryopreservation Media market.

    Cryopreservation Media Market Key Players

Video Summary for Cryopreservation Media Market

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cryopreservation Media Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Cryopreservation Media Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Cryopreservation Media Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Cryopreservation Media Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Cryopreservation Media Market Size & Forecast, 2016-2031
      4.5.1 Cryopreservation Media Market Size and Y-o-Y Growth
      4.5.2 Cryopreservation Media Market Absolute $ Opportunity
Chapter 5 Global Cryopreservation Media Market Analysis and Forecast By Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Type
      5.1.2 Basis Point Share (BPS) Analysis By Type
      5.1.3 Absolute $ Opportunity Assessment By Type
   5.2 Cryopreservation Media Market Size Forecast By Type
      5.2.1 Serum-Free
      5.2.2 With Serum
   5.3 Market Attractiveness Analysis By Type
Chapter 6 Global Cryopreservation Media Market Analysis and Forecast By End-user
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By End-user
      6.1.2 Basis Point Share (BPS) Analysis By End-user
      6.1.3 Absolute $ Opportunity Assessment By End-user
   6.2 Cryopreservation Media Market Size Forecast By End-user
      6.2.1 Pharmaceutical & Biotechnology Companies
      6.2.2 Academic & Research Institutes
      6.2.3 Cell Banks
      6.2.4 Others
   6.3 Market Attractiveness Analysis By End-user
Chapter 7 Global Cryopreservation Media Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Cryopreservation Media Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact
   8.1 Introduction
   8.2 Current & Future Impact Analysis
   8.3 Economic Impact Analysis
   8.4 Government Policies
   8.5 Investment Scenario
Chapter 9 North America Cryopreservation Media Analysis and Forecast
   9.1 Introduction
   9.2 North America Cryopreservation Media Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Cryopreservation Media Market Size Forecast By Type
      9.6.1 Serum-Free
      9.6.2 With Serum
   9.7 Basis Point Share (BPS) Analysis By Type
   9.8 Absolute $ Opportunity Assessment By Type
   9.9 Market Attractiveness Analysis By Type
   9.10 North America Cryopreservation Media Market Size Forecast By End-user
      9.10.1 Pharmaceutical & Biotechnology Companies
      9.10.2 Academic & Research Institutes
      9.10.3 Cell Banks
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis By End-user
   9.12 Absolute $ Opportunity Assessment By End-user
   9.13 Market Attractiveness Analysis By End-user
Chapter 10 Europe Cryopreservation Media Analysis and Forecast
   10.1 Introduction
   10.2 Europe Cryopreservation Media Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Cryopreservation Media Market Size Forecast By Type
      10.6.1 Serum-Free
      10.6.2 With Serum
   10.7 Basis Point Share (BPS) Analysis By Type
   10.8 Absolute $ Opportunity Assessment By Type
   10.9 Market Attractiveness Analysis By Type
   10.10 Europe Cryopreservation Media Market Size Forecast By End-user
      10.10.1 Pharmaceutical & Biotechnology Companies
      10.10.2 Academic & Research Institutes
      10.10.3 Cell Banks
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis By End-user
   10.12 Absolute $ Opportunity Assessment By End-user
   10.13 Market Attractiveness Analysis By End-user
Chapter 11 Asia Pacific Cryopreservation Media Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Cryopreservation Media Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Cryopreservation Media Market Size Forecast By Type
      11.6.1 Serum-Free
      11.6.2 With Serum
   11.7 Basis Point Share (BPS) Analysis By Type
   11.8 Absolute $ Opportunity Assessment By Type
   11.9 Market Attractiveness Analysis By Type
   11.10 Asia Pacific Cryopreservation Media Market Size Forecast By End-user
      11.10.1 Pharmaceutical & Biotechnology Companies
      11.10.2 Academic & Research Institutes
      11.10.3 Cell Banks
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis By End-user
   11.12 Absolute $ Opportunity Assessment By End-user
   11.13 Market Attractiveness Analysis By End-user
Chapter 12 Latin America Cryopreservation Media Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Cryopreservation Media Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Cryopreservation Media Market Size Forecast By Type
      12.6.1 Serum-Free
      12.6.2 With Serum
   12.7 Basis Point Share (BPS) Analysis By Type
   12.8 Absolute $ Opportunity Assessment By Type
   12.9 Market Attractiveness Analysis By Type
   12.10 Latin America Cryopreservation Media Market Size Forecast By End-user
      12.10.1 Pharmaceutical & Biotechnology Companies
      12.10.2 Academic & Research Institutes
      12.10.3 Cell Banks
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis By End-user
   12.12 Absolute $ Opportunity Assessment By End-user
   12.13 Market Attractiveness Analysis By End-user
Chapter 13 Middle East & Africa (MEA) Cryopreservation Media Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Cryopreservation Media Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Cryopreservation Media Market Size Forecast By Type
      13.6.1 Serum-Free
      13.6.2 With Serum
   13.7 Basis Point Share (BPS) Analysis By Type
   13.8 Absolute $ Opportunity Assessment By Type
   13.9 Market Attractiveness Analysis By Type
   13.10 Middle East & Africa (MEA) Cryopreservation Media Market Size Forecast By End-user
      13.10.1 Pharmaceutical & Biotechnology Companies
      13.10.2 Academic & Research Institutes
      13.10.3 Cell Banks
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis By End-user
   13.12 Absolute $ Opportunity Assessment By End-user
   13.13 Market Attractiveness Analysis By End-user
Chapter 14 Competition Landscape
   14.1 Cryopreservation Media Market: Competitive Dashboard
   14.2 Global Cryopreservation Media Market: Market Share Analysis, 2022
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      14.3.1 Thermo Fisher Scientific Inc
      14.3.2 Lonza
      14.3.3 STEMCELL Technologies
      14.3.4 Merck KGaA
      14.3.5 Danaher (Cytiva)
      14.3.6 BioLife Solutions Inc.
      14.3.7 Bio-Techne
      14.3.8 Sartorius AG (Biological Industries)
      14.3.9 HiMedia Laboratories
      14.3.10 NIPPON Genetics EUROPE
      14.3.11 Capricorn Scientific
      14.3.12 PromoCell GmbH

Purchase Premium Report